Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Italian energy giant Eni SpA ( E - Analyst Report ) intends to expand its operations in the Ukraine’s shale gas arena. With this goal, Eni has entered into an agreement with the country’s state-owned national joint stock company Nak Nadra Ukrayny and independent oil and gas producer Cadogan Petroleum Plc.
The agreement gives Eni a controlling interest of 50.01% in LLC WestGasInvest, which currently has subsoil rights to nine unconventional gas license areas in the Lviv Basin of Ukraine, spanning over a total area of about 3,800 square kilometres.
This deal follows the news of Eni, along with its partners, being outbid by Royal Dutch Shell ( RDS.A - Analyst Report ) and Chevron Corporation ( CVX - Analyst Report ) for acres in the well-known Yuzivska and Olesska areas of the basin.
The Lviv Basin is considered to be among the basins with utmost potential in Europe for the exploration of unconventional gas. Further, the appraisal of Lublin Basin in Poland has also attracted considerable interest from the hydrocarbon industry.
Eni’s presence in the Ukraine dates back to 2011 when it signed the Zagoryanska and Pokroskoe licenses. Located in the Dniepr-Donetz Basin, Eni operates the licenses along with its partner Cadogan.
The deal is a major step by the company in its effort to build a worldwide unconventional portfolio. It will also help Eni to strengthen its position in Ukraine and provide a base to grow further in the country.
Eni also holds interest in 3 licenses in Poland’s Polish Basin. Currently, the company is operating in the Polish licenses, and leveraging its widespread knowledge and proficiency gained through its joint venture in the Barnett Shale in Texas.
Eni holds a Zacks #3 Rank, which translates to a Hold rating for a period of one to three months. Longer term, we maintain our Neutral recommendation on the stock.
Read the full reports :
Analyst Report on E
Analyst Report on CVX
Analyst Report on RDS.A